SUPREMA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23,750 KRW | +1.06% |
|
+3.94% | +13.91% |
| Mar. 22 | Tranche Update on Suprema Inc.'s Equity Buyback Plan announced on March 21, 2023. | CI |
| Mar. 22 | Tranche Update on Suprema Inc.'s Equity Buyback Plan announced on March 21, 2023. | CI |
| Sales 2024 * | 110B 80.45M | Sales 2025 * | 124B 90.23M | Capitalization | 164B 120M |
|---|---|---|---|---|---|
| Net income 2024 * | 21B 15.33M | Net income 2025 * | 26B 18.98M | EV / Sales 2024 * | 0.78 x |
| Net cash position 2024 * | 78.2B 57.09M | Net cash position 2025 * | 88.2B 64.39M | EV / Sales 2025 * | 0.61 x |
| P/E ratio 2024 * |
7.3
x | P/E ratio 2025 * |
6.18
x | Employees | 206 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.08% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.06% | ||
| 1 week | +3.94% | ||
| Current month | -0.42% | ||
| 1 month | -1.66% | ||
| 3 months | -13.64% | ||
| 6 months | +23.06% | ||
| Current year | +13.91% |
1 week
21 750.00
23 900.00
1 month
21 550.0024 550.00
Current year
20 250.0029 150.00
1 year
19 020.0029 150.00
3 years
19 020.0030 300.00
5 years
19 020.0048 000.00
10 years
15 200.0048 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Han-Chul Kim
CEO | Chief Executive Officer | 54 | - |
Jae-Won Lee
CEO | Chief Executive Officer | 55 | - |
Hee-Su Yang
DFI | Director of Finance/CFO | 56 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jae-Won Lee
CEO | Chief Executive Officer | 55 | - |
Bong-Seob Song
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Hee-Su Yang
DFI | Director of Finance/CFO | 56 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 23,750 | +1.06% | 25,212 |
| 24-04-22 | 23,500 | +0.86% | 32,483 |
| 24-04-19 | 23,300 | 0.00% | 55,344 |
| 24-04-18 | 23,300 | +5.19% | 63,029 |
| 24-04-17 | 22,150 | +0.91% | 212,119 |
End-of-day quote Korea S.E., April 22, 2024
More quotes
Suprema Inc. is a Korea-based company engaged in the biometrics business. The Companyâs offerings consist of fingerprint systems and fingerprint solutions. Its fingerprint systems include Internet protocol (IP)-based access control and time attendance terminals under the brand names of BioStation, D-Station, FaceStation, BioEntry, BioLite and others. Its fingerprint solutions are used in its related fingerprint systems. The Company distributes its products within domestic market and to overseas markets.
Sector
Electronic Equipment & Parts
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +13.91% | 118M | |
| -30.18% | 1.36B | |
| +196.26% | 167M | |
| +21.13% | 82.36M | |
| -48.84% | 50.72M |
- Stock Market
- Equities
- A236200 Stock
